BIOTECHNOLOGY INDUSTRY CONFERENCE IN AUSTRALIA

For decades, AusBiotech has united Australia's life science industry, connecting people, ideas, and opportunities. The flagship conference is the largest week in biotechnology and life sciences, celebrating Australian life science innovation – from groundbreaking research to advanced medical technologies and therapies. As a super-connector event, it drives important domestic dialogue within our industry, fosters collaboration, informs policy, and builds long-term partnerships, enabling Australia's life science ecosystem to thrive. With increasing international attendees, the conference also highlights Australia's growing opportunities to further expand collaborative potential, leverage global interest in our research, and develop and commercialize indigenous innovations. From 2025, this unparalleled gathering of industry leaders, innovators, entrepreneurs, and researchers will be known as the AusBiotech International Conference.

Based on the exhibition theme, the exhibit range of the AusBiotech Brisbane Biotechnology Conference and Exhibition in Australia will broadly cover various aspects of the biotechnology field, aiming to comprehensively showcase the latest achievements and development trends in the Australian and global biotechnology industries. Specific exhibits may include: 1. **Biopharmaceuticals and Therapies**: Covering novel vaccines, antibody drugs, cell and gene therapies, nucleic acid drugs (RNAi, mRNA), small molecule drugs, peptide drugs, and innovative therapies for major diseases such as cancer, autoimmune diseases, and rare diseases. 2. **Diagnostic Technologies and Equipment**: Including molecular diagnostic reagents and platforms (PCR, NGS), immunoassay, POCT (Point-of-Care Testing) devices, biosensors, medical imaging technologies, and advanced diagnostic tools for early disease screening, personalized medication guidance, and prognosis monitoring. 3. **Research Instruments and Reagents**: Showcasing various high-end instruments and equipment required for life science research, such as gene sequencers, mass spectrometers, flow cytometers, high-content imaging systems, as well as related biological reagents, consumables, and laboratory solutions. 4. **Agricultural and Food Biotechnology**: Focusing on gene-edited crops, biopesticides, animal vaccines, functional foods, and innovative applications utilizing biotechnology to improve agricultural product quality, increase yield, and enhance resistance. 5. **Industrial and Environmental Biotechnology**: Including biocatalysts, bio-based materials, bioenergy (such as biofuels), and bioprocesses and solutions for environmental remediation and sustainable production. 6. **Contract Services and Outsourcing (CRO/CDMO)**: Providing biotechnology companies with full-process outsourcing services from drug discovery, preclinical research, clinical trials to commercial production, including toxicology studies, pharmacokinetic analysis, formulation development, and large-scale manufacturing. 7. **Digital Health and Artificial Intelligence**: Showcasing innovative solutions that leverage big data, artificial intelligence, and machine learning to empower drug research and development, clinical decision support, health management, and personalized medicine.

No fee information available. Please contact us for a quote.